MedPath
NMPA Approval

Imipenem, Cilastatin Sodium and Relebactam for Injection

国药准字HJ20240140

December 1, 2024

Drug Information

注射用亚胺西瑞

注射剂

1.25g(C₁₂H₁₇N₃O₄S 0.5g,C₁₆H₂₆N₂O₅S 0.5g与C₁₂H₂₀N₄O₆S 0.25g)

化学药品

December 1, 2024

November 30, 2029

Company Information

Applicant Company

Waarderweg 39, 2031 BN Haarlem, The Netherlands

Manufacturing Company

Merck, Inc.

2778 South East Side Highway, Elkton, VA 22827, USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用亚胺西瑞 - NMPA 批准文号 | MedPath